Table 1 |
|||
|
|
|||
|
No CKD (n = 29) |
New CKD (n = 12) |
P value |
|
|
|
|||
|
Age |
31.3 |
34.3 |
NS |
|
Male (%) |
14 |
0 |
- |
|
African American (%) |
28 |
50 |
- |
|
Mean starting SCr (mg/dl) |
0.85 ± 0.15 |
0.75 ± 0.15 |
NS |
|
Mean end SCr (mg/dl) |
0.83 ± 0.12 |
1.78 ± 1.95 |
0.0001 |
|
Median time in flare (months) |
0 |
20 |
0.0003 |
|
Mean new RF/year |
0.14 |
0.72 |
0.0001 |
|
Median time in renal health (months) |
52 |
30.4 |
0.0038 |
|
|
|||
|
Parikh et al. Arthritis Research & Therapy 2012 14(Suppl 3):A45 doi:10.1186/ar3979 |
|||